Russian Sputnik V vaccine gets credibility boost in Lancet review

By bne IntelliNews February 3, 2021

The Russian vaccine Sputnik V has shown to be 91.6% efficient against symptomatic coronavirus (COVID-19) in clinical trials, a Lancet peer review has confirmed, bringing the Russian vaccine among the ...

This content is only available to Intellinews Pro users.

If you a Pro users click to login or request a trial.

Thank You,
bne IntelliNews Team